文献速递瓣膜外科

经心尖心脏不停跳非体外循环下新腱索二尖瓣修复的5年良好耐久性

Good 5-Year Durability of Transapical Beating Heart Off-Pump Mitral Valve Repair With Neochordae.
PubMed 文献 · Ann Thorac Surg · 2018-05-02

该研究评估NeoChord系统经心尖心脏不停跳非体外循环下植入新腱索修复二尖瓣脱垂的长期结果。6例重度原发性二尖瓣反流患者中5例成功修复,1例因瓣叶损伤中转开放二尖瓣置换;2例分别于术后3和16个月因复发反流再手术,余3例随访5年无心脏症状,超声示微量或轻至中度反流。

要点

  • 6例重度原发性二尖瓣反流患者接受NeoChord系统经心尖心脏不停跳非体外循环下新腱索植入。
  • 5例成功修复至无或微量反流,1例因瓣叶损伤中转开放二尖瓣置换。
  • 2例分别于术后3和16个月因复发反流再手术,余3例随访5年无心脏症状。

核心结论

  • 在经选择的患者中,使用NeoChord系统行二尖瓣修复可获得很好的长期结果,无复发性脱垂、反流或瓣环扩张。

研究设计与样本

  • 研究为初始器械安全性和可行性Transapical Artificial Chordae Tendinae(TACT)试验的一部分,在莱比锡大学心脏中心(德国莱比锡)纳入6例重度原发性二尖瓣反流患者,接受NeoChord DS1000系统治疗。
  • 所有患者的主要病变为孤立的P2或P3段或两者后叶脱垂。

主要发现

  • 6例患者中5例在经食管超声心动图引导和正常左心室负荷条件下植入3根新腱索,成功修复至无或微量二尖瓣反流。
  • 1例因瓣叶损伤术中中转开放二尖瓣置换。
  • 其余患者早期术后病程平稳。
  • 2例分别于术后3和16个月因复发二尖瓣反流再手术。
  • 剩余3例随访5年,无心脏症状,经胸超声心动图在1年、2年和5年随访时显示微量或轻至中度二尖瓣反流。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transapical, beating heart, off-pump implantation of neochordae for repair of mitral valve (MV) prolapse is of increasing interest. The aim of this study was to evaluate long term results for MV repair using the NeoChord system (NeoChord, St. Louis Park, MN). METHODS: Six patients underwent treatment for severe primary mitral regurgitation (MR) with the NeoChord DS1000 system as part of the initial device safety and feasibility Transapical Artificial Chordae Tendinae (TACT) trial at our institution (University of Leipzig-Heart Center, Leipzig, Germany). The primary pathology in all patients was isolated posterior leaflet prolapse of the P2 or P3 segment, or both. RESULTS: Successful repair resulting in no or trace MR was achieved in 5 of 6 patients by implantation of three neochordae under transesophageal echocardiographic guidance and normal left ventricular loading conditions. One patient underwent intraoperative conversion to an open MV replacement as a result of leaflet injury. The early postoperative course was uneventful in all remaining patients. Two patients had to undergo reoperation for recurrent MR at 3 and 16 months postoperatively. The remaining 3 patients were followed up for a period of 5 years. These patients were free of cardiac symptoms, and transthoracic examination showed trace or mild to moderate MR at 1-, 2-, and 5-year follow-up. A trend toward reverse remodeling of the left ventricle with no increase in mitral annular dilatation over 5 years was observed. CONCLUSIONS: In select patients, MV repair using the NeoChord system results in very good long-term results without recurrent prolapse, MR, or annular dilatation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kiefer P, Meier S, Noack T, et al. Good 5-Year Durability of Transapical Beating Heart Off-Pump Mitral Valve Repair With Neochordae. Ann Thorac Surg. 2018. PMID: 29729267. doi:10.1016/j.athoracsur.2018.01.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。